Healthcare

This edition depicts medical and diagnostic and imaging innovations in UK. Quantitative reading software, medical scanner to augment 3D bio-printing, radiowave radar technology for imaging breast cancer, non-invasive imaging approach for detection of prostate cancer, oxygen-enhanced MRI for lung diseases, intra-cellular ultrasound imaging, PACS sys...

This edition of Genetic Technology TOE profiles trends in genomic techniques across the United States. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the e...

3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medic...

Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 sp...

This edition of the Medical Device TOE profiles MedTech innovations from UK. The innovations profiled in this issue have predominantly been developed by start-ups or early-stage companies, with plenty of potential for commercial application within and outside UK. Featuring both products and services, these innovations pertain to markets such as cli...

This edition of Genetic TOE profiles life sciences trends across diabetes and obesity management. The corresponding patent scenario is depicted along with the industry interactions. The Genetic TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of...

This edition of the Drug Discovery TOE depicts trends across orphan drugs in North America. Compared with standard drugs, orphan drugs involve fewer clinical trial issues. Typically, orphan drugs spend less time in regulatory review, comprise smaller phase III trial sizes, and are more likely to be approved by the US Food and Drug Administration (F...

This edition of Genetic Technology TOE profiles life sciences trends in start-ups across the life science industry. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to pro...

This edition of Inside R&D TOE profiles innovations in hydrogels, medical stents, photovoltaic energy, biofertilizers, and text analytics. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wi...